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ABSTRACT 
The discovery of tumour selective virus-mediated apoptosis marked the birth of an alternative 
cancer treatment in the form of oncolytic viruses. Even though, its oncolytic efficiency was 
demonstrated more than 50 years ago, safety concerns which resulted from mild to lethal side 
effects hampered the progress of oncolytic virus research. Since the classical oncolytic virus 
studies rely heavily on its natural oncolytic ability, virus manipulation was limited, thereby, 
restricted efforts to improve its safety. In order to circumvent such restriction, experiments 
involving non-human viruses such as the avian Newcastle disease virus (NDV) was 
conducted using cultured cells, animal models and human subjects. The corresponding 
reports on its significant tumour cytotoxicity along with impressive safety profile initiated 
immense research interest in the field of oncolytic NDV. The varying degree of oncolytic 
efficiency and virulency among NDV strains encouraged researchers from all around the 
world to experiment with their respective local NDV isolates in order to develop an oncolytic 
virus with desirable characteristics. Such desirable features include high tumour-killing 
ability, selectivity and low systemic cytotoxicity. The Malaysian field outbreak isolate, NDV 
strain AF2240, also currently, receives significant research attention. Apart from its high 
cytotoxicity against tumour cells, this strain also provided fundamental insight into NDV-
mediated apoptosis mechanism which involves Bax protein recruitment as well as death 
receptor engagement. Studies on its ability to selectively induce apoptosis in tumour cells 
also resulted in a proposed p38 MAPK/NF-κB/IκBα pathway. The immunogenicity of 
AF2240 was also investigated through PBMC stimulation and macrophage infection. In 
addition, the enhanced oncolytic ability of this strain under hypoxic condition signifies its 
dynamic tumour tropism. This review is aimed to introduce and discuss the aforementioned 
details of the oncolytic AF2240 strain along with its current challenges which outlines the 
future research direction of this virus. 
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